SOLID NEOPLASM
Clinical trials for SOLID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new SOLID NEOPLASM trials appear
Sign up with your email to follow new studies for SOLID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new Two-Pronged attack on tough cancers
Disease control OngoingThis early-stage study is testing a new combination of drugs for people with advanced solid tumors or non-Hodgkin lymphoma that has spread. The main goal is to find the safest and most effective dose by combining an experimental drug called veliparib with standard chemotherapy dr…
Matched conditions: SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Heat-and-Zap combo fights spine tumors
Disease control OngoingThis study is testing whether using two treatments together works better than one to control cancer that has spread to the spine and is at risk of pressing on the spinal cord. Doctors combine a heat treatment (thermal ablation) that destroys tumor cells with a very precise, high-…
Matched conditions: SOLID NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Scientists test Two-Drug attack on tough brain and solid tumors
Disease control OngoingThis early-stage study is testing the safety and best dose of a new oral drug, MLN0128, when given with the existing cancer drug bevacizumab. It is for adults with recurrent glioblastoma (a type of brain tumor) or other advanced solid tumors that have stopped responding to standa…
Matched conditions: SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope pill tested for kids with tough cancers
Disease control OngoingThis study is testing whether a pill called cabozantinib can help control rare cancers that have come back or stopped responding to other treatments in children and young adults. It includes patients with sarcomas, Wilms tumor, and other rare tumors. The drug aims to slow or stop…
Matched conditions: SOLID NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test tailored drug dosing to fight tough cancers
Disease control OngoingThis early-stage study is testing a method to personalize the dose of a cancer drug called pazopanib for patients with advanced solid tumors. Researchers will check drug levels in patients' blood and adjust the dose to try to improve safety and effectiveness. The main goal is to …
Matched conditions: SOLID NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Targeted drug trial offers hope for kids with rare, Hard-to-Treat cancers
Disease control OngoingThis study is testing a targeted drug called larotrectinib in children and young adults (up to age 30) with specific types of cancer. The cancers must have a rare genetic change called a TRK fusion. The goal is to see if the drug can shrink tumors or control leukemia before other…
Matched conditions: SOLID NEOPLASM
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Study scans how local cancer centers use genetic tests
Knowledge-focused TerminatedThis study aimed to understand how community cancer clinics test for biomarkers—specific genetic changes in tumors—to help guide treatment decisions for common cancers like breast, lung, and colorectal. It planned to survey pathology labs to see what tests they run, how quickly t…
Matched conditions: SOLID NEOPLASM
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC